Release Date: 02/04/15 15:55 Summary: Change of Director's Interest Notice - Amended Price Sensitive: No Download Document 70.93KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%